tocilizumab,cevostamab
roche
['mmsm', 'tocilizumab', 'toci', 'multiple myeloma', 'cevostamab']
pretreatment with tocilizumab prior to the cd3 bispecific cevostamab in patients with relapsed/refractory multiple myeloma (rrmm) showed a marked reduction in cytokine release syndrome incidence and severity. #ash22 #mmsm
Hematology is in my ??. Posts are mine. Mayo Clinic Associate, Asst Prof, BMT RNCC, RN Navigator, emeritus. IMF NLB. MM KOL. Patient educator & advocate.